1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn'tThe Motley Fool • 06/03/26
How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026Zacks Investment Research • 05/27/26
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetesPRNewsWire • 05/27/26
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screeningPRNewsWire • 05/27/26
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026PRNewsWire • 05/26/26
The Dip That Keeps On Dipping: 2 Strong Buy Stocks Near 52-Week Lows With 50%+ Upside PotentialSeeking Alpha • 05/19/26
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?Zacks Investment Research • 05/18/26
Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?Zacks Investment Research • 05/13/26
Abbott's Medical Device Strategy Supports Long-Term Growth OutlookZacks Investment Research • 05/08/26
Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week LowsThe Motley Fool • 05/06/26